12:00 AM
 | 
Mar 06, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Periostat orally administered enzyme inhibitor regulatory update

The U.K. Medicines Control Agency granted marketing approval for CGPI's Periostat as an...

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >